CliffBio
small molecule

RIZAFILM

RIZATRIPTAN BENZOATE

Loss of exclusivity—loss of exclusivity
CompanyGENSCO LABORATORIES LLC DBA GENSCO PHARMA

Drug detail

Brand nameRIZAFILM
Active ingredientRIZATRIPTAN BENZOATE
StrengthEQ 5MG BASE
Dosage formFILM
RouteORAL
ModalitySmall molecule
FDA approvalFebruary 2026
Marketing statusRX

More from GENSCO LABORATORIES LLC DBA GENSCO PHARMA

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

RIZAFILM patent cliff — loss of exclusivity — | CliffBio